Clinical Research AND Research Ethics

The answer first

Valid design plus ethical conduct equals generalisable knowledge. Recognise the study design, judge its internal and external validity against an explicit risk-of-bias framework, and confirm that consent, oversight and conflict-of-interest safeguards satisfy the Declaration of Helsinki before you accept a conclusion into practice.^[1][6]

The randomised controlled trial is the gold standard for causal inference; systematic reviews synthesise those trials transparently; and observational designs answer the questions randomisation cannot — the harm of smoking, the natural history of a rare disease. Each has its place, and the physician's job is to know which tool answers which question.^[1][2]

The consultant physician must be able to read a published trial, place it in the hierarchy of evidence, articulate the threats to its validity (selection, performance, detection, attrition, reporting bias), and defend the ethical framework — autonomy, beneficence, non-maleficence, justice — that governs enrolment of patients into research. ^{[5] [11]} This page covers that landscape with the depth the DCE expects: study design hierarchy, bias, randomisation and blinding, ethics principles, consent, conflicts of interest, misconduct and retraction, and the reporting guidelines that make evidence auditable. ^{[1] [2]}

References12ShowHide

1. [1]Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ, 2010.PMID 20332509
2. [2]Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021.PMID 33782057
3. [3]Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med, 2013.PMID 23295957
4. [4]Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol, 2008.PMID 18313558
5. [5]Freedman B Equipoise and the ethics of clinical research. N Engl J Med, 1987.PMID 3600702
6. [6]World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA, 2013.PMID 24141714
7. [7]Guarino PD, Vertrees JE, Asthana S, et al. Measuring informed consent capacity in an Alzheimer's disease clinical trial. Alzheimers Dement (N Y), 2016.PMID 29067313
8. [8]Topol EJ Conflict-of-interest policies. N Engl J Med, 2001.PMID 11280315
9. [9]Wager E, Kleinert S Cooperation between research institutions and journals on research integrity cases: guidance from the Committee on Publication Ethics (COPE). Maturitas, 2012.PMID 22541357
10. [10]Rosenberger WF, Uschner D, Wang Y Randomization: The forgotten component of the randomized clinical trial. Stat Med, 2019.PMID 30047159
11. [11]Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 2011.PMID 22008217
12. [12]McQuay HJ, Moore RA Placebo. Postgrad Med J, 2005.PMID 15749790